Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 3, 2010, Pages 312-318

  Xin, Ming Jun ^a,b   Cui, Shi Hua ^a,c   Liu, Shuang ^a   Sun, Hai Chen ^a   Li, Fei ^a   Sun, Jia Bang ^a   Luo, Bin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Glucose tolerance test; Immunosuppression; Islet transplantation; Non obese diabetic mice; Triptolide

Indexed keywords

CYCLOSPORIN A; TRIPTOLIDE; CYCLOSPORIN; DITERPENE; EPOXIDE; GLUCOSE BLOOD LEVEL; IMMUNOSUPPRESSIVE AGENT; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; SURVIVAL TIME; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; TIME; TOXICITY; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; CYCLOSPORINE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DITERPENES; EPOXY COMPOUNDS; FEMALE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; PHENANTHRENES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; WEIGHT GAIN;

EID: 77953832101     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069. (Pubitemid 40911269)
2. Larsen JL, Bennett RG, Burkman T, Ramirez AL, Yamamoto S, Gulizia J, et al. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation 2006;82:466-470.
3. Tao XL, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, et al. A prospective, controlled, double-blind, cross-over study oftripterygium wilfodii hook F in treatment of rheumatoidarthritis. Chin Med J (Engl) 1989;102:327-332.
4. Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-1281.
5. Gu WZ, Chen R, Brandwein S, McAlpine J, Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int J Immunopharmacol 1995;17:351-356.
6. Yang SX, Xie SS, Gao HL, Ma DL, Long ZZ. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. Int J Immunopharmacol 1994;16:895-904.
7. Lu H, Hachida M, Enosawa S, Li XK, Suzuki S, Koyanagi H. Immunosuppressive effect of triptolide in vitro. Transplant Proc 1999;31:2056-2057.
8. Yang SX, Gao HL, Xie SS, Zhang WR, Long ZZ. Immunosuppression of triptolide and its effect on skin allograft survival. Int J Immunopharmacol 1992;14:963-969.
9. Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000;70:447-455. (Pubitemid 30641499)
10. Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999;274:13443-13450.
11. Liu Q, Chen T, Chen H, Zhang M, Li N, Lu Z, et al. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. Biochem Biophys Res Commun 2004;319:980-986.
12. Liu Q, Chen T, Chen G, Shu X, Sun A, Ma P, et al. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol Immunol 2007;44:2686-2696.
13. Chen T, Xu H, Wang HQ, Zhao Y, Zhu CF, Zhang YH, et al. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrowderived dendritic cells. Transplant Proc 2008;40:3711-3713.
14. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985;40:437-438.
15. Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response. Int Immunopharmacol 2003;3:1457-1465.
16. Gu WZ, Brandwein SR. Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol 1998;20:389-400.
17. Li R, Takazawa K, Suzuki H, Hariya A, Yamamoto T, Matsushita S, et al. Synergistic effect of triptolide and tacrolimus on rat cardiac allotransplantation. Jpn Heart J 2004;45:657-665.
18. Zhang G, Liu Y, Guo H, Sun Z, Zhou YH. Triptolide promotes generation of FoxP3+ T regulatory cells in rats. J Ethnopharmacol 2009;125:41-46.
19. Liu Y, Chen Y, Liu FQ, Lamb JR, Tam PK. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. Transpl Int 2008;21:483-494.
20. Matta R, Wang X, Ge H, Ray W, Nelin LD, Liu Y. Triptolide induces anti-inflammatory cellular responses. Am J Transl Res 2009;1:267-282.
21. Hu KB, Liu ZH, Guo XH, Liu D, Li LS. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells. Acta Pharmacol Sin 2001;22:651-656. (Pubitemid 32656496)
22. Ji SM, Wang QW, Chen JS, Sha GZ, Liu ZH, Li LS. Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China. Transplant Proc 2006;38:1274-1279.